Are you interested in exploring ongoing clinical trials for at the University of Alabama at Birmingham?


Top 10 Hospitals and Doctors for Leukemia

Top ten hospitals and doctors for leukemia

In plain and simple words, many times, the diagnosis of cancer does more damage than the disease itself. Thankfully, cancer research has made some substantial strokes lately and it is no more a scary ticking bomb. Timely diagnosis and right treatment decisions can rewrite a person’s health destiny. You can outgrow cancer!

Cancer survivorship is all about carrying your best weapons against cancer, crushing it inch by inch. It’s all in the mindset, after all. It is a right thing to say that feed your faith and your fears will undergo apoptosis (planned death). As a patient, you have to dump your frustration in the fuel tank of your body and then sit behind the wheel. Unless you allow the cancer to creep in your soul and substance, it can wreak no havoc. It only wields power when you allow it to.

However, the most important, and often the first, decision in the cancer treatment is the selection of hospital and doctor. We, at Xpertdox, are a team of highly competent, qualified and versatile doctors, and we have created scientific algorithms that study billions of data points before giving you a list of best doctors and hospitals for every type of cancer.

Let’s talk about LEUKEMIA in this post – the top 10 hospitals and top 10 doctors in the U.S.


Brigham and Women's Cancer Center: This marvel of human compassion and exemplary clinical finesse has an unflinching focus on mastering the methods to conquer cancer and fine-tuning the way the cancer care is conceptualized and delivered. Through the joining hands of twelve specialized disease management centers, clinical stalwarts from the topmost cancer Institutes of global recognition, and one of the world's leading hospitals, the most revolutionizing cancer treatments are offered. Fuelled by the consistent quest to conquer cancer, this cancer center provides exceptionally tender and qualified care that makes all the difference.

For over 70 years, Brigham and Women’s Cancer Center has successfully led the world by making cutting-edge breakthroughs in cancer research, patient care and highly-focused treatment1. The Center offers a quick access program to help newly-diagnosed adult patients by providing appointments with an oncologist as soon as the next day. They specialize in offering individual cancer treatment plan to avant-garde therapies based on the genetic profiling and other unique biological needs. The physicians and researchers have contributed hugely in development of many of the latest anticancer weaponry - from immune system exploration to tumor-targeted therapies based on the DNA sequencing.

The Johns Hopkins Hospital: The Johns Hopkins Hospital is a non-profit academic medical center in Baltimore, Maryland holding superlative reputation in the realms of cancer treatment. It is a trend-setting healthcare organization with prolific experience in cancer treatment, patient care, research and education. Since its opening in 1973, this Cancer Center has spearheaded the quest against cancer. It has facilitated the world understanding various mechanisms of cancer and help designing novel ways to treat it2. The Johns Hopkins Kimmel Cancer Center has active and innovative programs in clinical research, laboratory research, medical education, community outreach, and prevention and control.

It was one of the earliest centers having been awarded comprehensive cancer center status and recognition as a “Center of Excellence” by National Cancer Institute. The center has active programs in cancer research, higher education, community outreach, and prevention and control. Their mission is to provide full range of evidence based, preventive, diagnostic, therapeutic, supportive and patient-centric services to cancer patients and their loved ones with compassion and support.

MD Anderson Center, The University of Texas: A globally renowned cancer care center, MD Anderson is well distinguished for decades of deep-rooted experience, top national rankings and leadership in cancer prevention and treatment. As part of the quest to completely eliminate cancer, MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers. Clinical trials fulfil the defining role of MD Anderson’s mission to end cancer. Aptly fitting in the role of one of the largest cancer centers in the world, MD Anderson has been putting in unparalleled efforts to eliminate cancer for more than seven decades3.

They have more nurses per patient than many hospitals in the country, to make sure that the highest quality attention and unmatched care is made available to every patient, at every hour. Also, MD Anderson is world-renowned for developing front-line diagnostic technology, which facilitates doctors explore and identify each patient’s unique cancer needs and tailor treatment for the most efficient clinical outcome.

Winship Cancer Institute, Emory University Hospital, GA: Winship Cancer Institute is holds the reputation of a national leader in seeking out extraordinarily novel ways to sabotage cancer and in converting that knowledge into excellent patient care. With over 250 active clinical trials, Winship researchers consistently make foray into taking new cancer treatments from bench to bedside.

The Lyda Hill Cancer Prevention Center provides 360 degree cancer risk assessment, screening for huge variety of cancers and diagnostic services. Their world-class physicians have colossal experience in medical oncology, radiation oncology, surgical oncology and diagnostic pathology. Magnet recognition has been granted by the American Nurses Credentialing Center, which ensures that rigorous standards for nursing excellence are met. The nurses, social workers, technicians and other healthcare workers are all part of the eminent cancer care team.

Memorial Sloan Kettering Cancer Center, NY: Memorial Sloan Kettering is at the forefront of the notable cancer research programs throughout the world and its physicians conduct one of the world’s largest clinical cancer research programs. As the world’s oldest and largest private cancer center, Memorial Sloan Kettering Cancer Center is comprehensively equipped to care for children, adolescents, and adults with all types of rare and common cancers.

Their pediatric cancer program is the largest of its kind in the U.S., with more than 800 new patients each year, giving them a weighty expertise in this domain of cancer care. The teams of physician-researchers work closely with biomedical scientists and investigators to translate basic findings into genuinely ground-breaking therapies. Treatments pioneered at Memorial Sloan Kettering are now the standard of care at many other institutions.

Emory University Hospital Midtown, GA: Emory University Hospital Midtown is recognized to be Georgia's NCI Comprehensive Cancer Center with remarkable distinction in the milieu of cancer research, innovation, and discovery. Their cancer programs are evidence-based, precise, impactful and well-governed. The four research programs include Cancer Cell Biology, Cancer Genetics and Epigenetics, Cancer Prevention and Control, and Discovery and Developmental Therapeutics.

The Cancer Cell Biology research program has the central theme of tumor signaling at its pivot in the context tumor microenvironment, for the development of therapeutic target discovery, cancer prevention, cancer prediction, biomarker and drug development. Cancer Genetics and Epigenetics research program works to probe fundamental genetic alterations occurring at the DNA levels that are responsible for the initiation, development and progression of cancers4. The strategic aim of the Discovery and Developmental Therapeutics research program is to foster a research environment to promote molecular target interrogation for cancer drug discovery. It also facilitates precisely translational clinical trials for development of appropriate therapeutic interventions.

New York-Presbyterian Hospital: The cancer specialists at NewYork-Presbyterian provide exceptional expertise, compassionate care and all-encompassing support to children, adolescents and adults with cancer. NewYork-Presbyterian is home to three leading cancer care programs – (1) Herbert Irving Comprehensive Cancer Center of New York-Presbyterian/Columbia University Medical Center (the National Cancer Institute-designated), (2) the NewYork-Presbyterian/Weill Cornell Ronald P. Stanton Clinical Cancer Program, and (3) the Weill Cornell Medicine Sandra and Edward Meyer Cancer Center.

As a cancer center of stellar repute, NewYork-Presbyterian treats approximately 7,500 newly diagnosed adult and pediatric cancer patients each year. The team of physician-scientists and researchers are leading more than 500 clinical trials with thousands of patients enrolled in them. Evidence-based therapies of virtually every type of cancer are being done here, with exceptionally good results, such as latest chemotherapy regimens, targeted agents, radiation therapies, bone marrow transplantation programs and robotic and other minimally invasive surgeries.

Massachusetts General Hospital: An integral part of one of the world's most distinguished academic medical centers, the Mass General Cancer Center offers a coordinated team approach tailored to the individual needs of each patient, and is among the outstanding cancer care providers of the country. Specialized clinical centers and programs are conducted to ensure that every patient benefits from a team of cancer specialists who excel in providing treatment and care about particular cancer type.

Known for providing well-tailored, innovative treatments and compassionate cancer care, the Cancer Center houses more than 37 treatment programs within 29 multidisciplinary disease centers5. The Massachusetts General Hospital Cancer Center is a founding member of a Harvard Medical School consortium designated by the National Cancer Institute as a comprehensive cancer center. This esteemed seven-member center forms the largest and one of its kind cancer research collaboration in the country. The promising new treatments conceptualized and developed through this partnership have brought sea-change to the future of precision based cancer medicine.

Hospital of the University of Pennsylvania: In 1973, the University of Pennsylvania founded a cancer center for all the cancer-related activities at the University. In 1974, it was designated as a comprehensive cancer center by NCI (National Cancer Institute) and in 2002, it was renamed the Abramson Cancer Center of the University of Pennsylvania6.

The Abramson Cancer Center is committed to eradicate cancer by investing hugely in hospital-based research programs. The Abramson Cancer Center for Personalized Diagnostics (CPD) is a joint initiative between the Abramson Cancer Center and Penn Medicine's Department of Pathology and Laboratory Medicine. This synergy enables the clinical oncologist to determine the best course of action for cancer treatment, based on the genomic test results and specific needs of the patient.

The Abramson Cancer Center has pioneered in innovative cancer care in a number of areas including: discovery of the Philadelphia Chromosome, which stands as the first working example that that abnormal chromosomes can cause cancer; development of antibody approaches to fighting cancer, path-breaking success in targeted cancer treatment, development  of transoral robotic surgery, providing evidence of sustained remissions of up to three years among a group of CLL (chronic lymphocytic leukemia) and LL (acute lymphocytic leukemia) patients treated with genetically engineered versions of their own T-cells; engineering a second generation of T-cells that can demolish and completely eradicate deadly ovarian cancer; and founding OncoLink – the first and most relevant cancer resource on the Internet.


Sonali M Smith, MD: Dr. Sonali Smith is Professor of Medicine in the Section of Hematology/Oncology at The University of Chicago and is nationally recognized lymphoma expert, currently serving as the Director of the Lymphoma Program. She has immense experience in the realms of lymphoma and holds special interest in the prognosis and biology of lymphoma, with a decisive aim to create personalize approaches based on individual risk factors.

David D. Hurd, MD:  Dr. David D. Hurd, the founder of the blood and marrow transplant program at Wake Forest, is an oncology specialist in Winston Salem, NC and has been practicing for about 44 years.

David Claxton, MD: Dr. David Claxton is hugely experienced in blood cancers and bears longstanding clinical interests in leukemia biology, molecular genetics and therapeutics. His clinical endeavors are directed at cancer drug development and clinical studies, blood and marrow transplantation, and clinical supportive care.

Edmund K Waller, MD, PhD: Dr. Edmund K Waller specializes in Medical Oncology and is a member of Emory Healthcare. A board certified hematologist, Dr. Waller has huge expertise in bone marrow transplants for acute leukemia, lymphoma, aplastic anemia, myelodysplastic syndrome, myeloproliferative neoplasms, Sickle cell disease and in the management of graft-versus-host disease.

Arnold S Freedman, MD: Dr. Freedman is a Professor of Medicine at Harvard Medical School, the Clinical Director of the Lymphoma Program at DFCI, a member of Dana-Farber Cancer Institute's Department of Medical Oncology, and an attending physician at Brigham and Women's Hospital.

Kenneth R Meehan, MD: Dr. Kenneth R Meehan is a top-rated oncologist in Lebanon, NH with over 17 areas of expertise, including Leukemia, Myeloma, and Lymphoma. Affiliated with Dartmouth-Hitchcock Medical Center, Dr. Meehan focuses on translational bio-oncology research, designing laboratory models to facilitate cancer clinical trials.

Bruce D Cheson, MD: Dr. Bruce Cheson is the Deputy Chief, Division of Hematology/Oncology and the Director of Hematology Research at Lombardi Comprehensive Cancer Center, Washington, DC. He has vast experience in applying leading-edge treatment regimens to his cancer patients with exemplary results.

Gary J Schiller, MD: Dr. Bruce Cheson is the Deputy Chief, Division of Hematology/Oncology at Lombardi Comprehensive Cancer Center. He has exceptional expertise over different hematological cancers, including Chronic Myeloid Leukemia, Acute Myeloid Leukemia and lymphomas.

Siddhartha Ganguly, MD: Dr. Siddhartha Ganguly is a hematologist in Westwood, Kansas and is affiliated with University of Kansas Hospital. He serves as the Director, Lymphoma/Myeloma Program and Professor, Research in Hematologic Malignancies, Stem cell and marrow transplantation.

Stefano R Tarantolo, MD: Dr. Stefano R Tarantolo is one of the best oncologists and hematologists in Omaha, NE with specialization and collosal expertise in the diagnosis and treatment of blood cancers such as leukemia, multiple myeloma, and lymphoma. With more than 33 years of clinical experience, Dr. Tarantolo applies latest oncology tools to get his patients on the road to recovery.